Training future scientists in brain cancer research
Neuro-Oncology Translational Research Training Program (NOTR-TP)
This program is all about training new researchers to help improve treatments for tough brain tumors like glioblastoma, so they can better support patients and make discoveries that connect lab work to real-life care.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11016161 on NIH RePORTER |
What this research studies
This program focuses on training the next generation of researchers in neuro-oncology, specifically targeting aggressive brain tumors like glioblastoma and brain metastases. It aims to provide comprehensive, multidisciplinary training that spans various fields such as oncology, neurology, and pharmacology. By mentoring both predoctoral and postdoctoral trainees, the program seeks to enhance research capabilities and clinical care for brain cancer patients. Participants will engage in translational research that bridges laboratory findings with clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are young scientists and clinicians interested in pursuing careers in neuro-oncology.
Not a fit: Patients currently receiving treatment for brain tumors will not directly benefit from this training program.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and outcomes for patients with brain tumors.
How similar studies have performed: Similar training programs in other institutions have successfully advanced neuro-oncology research and improved patient care.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Prins, Robert M — University of California Los Angeles
- Study coordinator: Prins, Robert M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.